Publications in collaboration with researchers from Universidad Católica San Antonio (2)

2023

  1. NLRP3 inflammasome activation and symptom burden in KRAS-mutated CMML patients is reverted by IL-1 blocking therapy

    Cell Reports Medicine, Vol. 4, Núm. 12

2016

  1. A polymorphism in FASL is associated with rituximab response in follicular lymphoma patients

    American Journal of Hematology